SPLENOMEGALY
Clinical trials for SPLENOMEGALY explained in plain language.
Never miss a new study
Get alerted when new SPLENOMEGALY trials appear
Sign up with your email to follow new studies for SPLENOMEGALY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for patients with rare, Hard-to-Treat blood disorders
Disease control Recruiting nowThis study is testing whether the drug ruxolitinib can help control rare blood disorders where the body makes too many eosinophils, a type of white blood cell. It will involve about 10 adults whose conditions have not responded well to standard treatments like steroids. The main …
Matched conditions: SPLENOMEGALY
Phase: PHASE2 • Sponsor: William Shomali • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New transplant strategy aims to tame deadly bone marrow cancer
Disease control Recruiting nowThis study is testing whether giving a high dose of the drug ruxolitinib, along with busulfan chemotherapy, before a stem cell transplant can help shrink an enlarged spleen and make the transplant more successful for people with myelofibrosis. Researchers will enroll about 30 pat…
Matched conditions: SPLENOMEGALY
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC